Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

100418

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases: Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether any Commissioning for Quality and Innovation payments are currently in operation relating to (a) liver disease and (b) hepatitis C.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211592
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>There are no Commissioning for Quality and Innovation (CQUIN) payments currently in operation relating to liver disease and hepatitis C. However, there are some local acute and community services CQUIN goals relating to specialist assessment or treatment for alcohol misuse, one of the major causes of liver disease.</p><p> </p><p> </p><p> </p><p>More detail on CQUINs can be found on NHS England’s website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/nhs-standard-contract/" target="_blank">http://www.england.nhs.uk/nhs-standard-contract/</a></p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:34:40 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

100421

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Royal Bournemouth Hospital
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what support NHS England is giving to the funding of robotic assisted surgical treatment for urology patients at the Royal Bournemouth Hospital; and if he will make a statement.
tabling member constituency	Christchurch
tabling member printed	Mr Christopher Chope
uin	211620
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We understand that NHS England has advised the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust that it should not offer robotic assisted surgical treatment until there is clearer national evidence of the effectiveness of the technique. However as the Trust is the identified surgical centre for urological cancer, NHS England’s Local Area Team and the local clinical commissioning group are working with all of the acute providers covering Dorset to ensure that patients have choice for timely surgery from Royal Bournemouth &amp; Christchurch Hospitals NHS Foundation Trust and other providers across Wessex and its environs.</p><p> </p><p> </p><p> </p><p>We are advised that the potential service and financial implications of NHS England’s proposed national clinical commissioning policy for robotic assisted surgery and service specification will be considered in the prioritisation process later this year. Further information will be posted on NHS England Website under the Specialised Cancer Clinical Reference Group when available.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:32:58 answering member 3918 label Biography information for Jane Ellison
tabling member	242 label Biography information for Sir Christopher Chope

100427

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Female Genital Mutilation: Greater London
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients treated at hospitals in South East London were known or suspected to have been subject to female genital mutilation in the last five years for which figures are available.
tabling member constituency	Lewisham, Deptford
tabling member printed	Dame Joan Ruddock
uin	211472
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The information is not available in the format requested. Such information as is available is in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p> </p></td><td><p>Active caseload<sup>2</sup></p></td><td><p>Newly identified<sup>3</sup></p></td></tr><tr><td colspan="2"><p>Hospital Trusts in South East London<sup>6</sup></p></td><td><p>337</p></td><td><p>52</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Female Genital Mutilation Prevalence Dataset (ISB 1610)</p><p> </p><table><tbody><tr><td><p><em>Notes</em></p></td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><p>1. The data is from the Female Genital Mutilation Prevalence Dataset (ISB 1610), a monthly return of data from acute hospital providers in England. It is an aggregated return of the incidence of FGM including women who have been previously identified and are currently being treated (for FGM related or non FGM related conditions as at the end of the month) and newly identified women within the reporting period. It has been a mandated collection from 1 September 2014. The first statistics from the Female Genital Mutilation Prevalence Dataset (ISB 1610) were published on 16 October 2014.</p></td></tr><tr><td colspan="4"><p>2. Patients identified as having a history of any FGM type prior to the reporting period and still being actively seen/treated for FGM-related conditions or any other non-related condition at the end of the month. Note: does not include those patients within NUMBER OF PATIENTS WITH FGM NEWLY IDENTIFIED IN REPORTING PERIOD (i.e. identified within this reporting period).</p></td></tr><tr><td colspan="4"><p>3. Patients first identified during the reporting period as having undergone FGM. This will include those diagnosed/identified within the provider within the month.</p></td></tr><tr><td colspan="4"><p>4. Data was submitted by trusts between the first and the tenth of October inclusive.</p></td></tr><tr><td colspan="4"><p>5. Only data that was submitted and signed off has been included.</p></td></tr></tbody></table><p> </p><p> </p><p> </p><table><tbody><tr><td><p>6. 'Hospital Trusts in South East London' has been defined as: Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Oxleas NHS Foundation Trust, South London and Maudsley NHS Foundation Trust. Only three of these trusts submitted data: Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust.</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:31:35 answering member 3918 label Biography information for Jane Ellison
tabling member	190 label Biography information for Dame Joan Ruddock

100428

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Mortuaries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average length of time was a deceased body spent in the mortuary of an English hospital in each year since 2004.
tabling member constituency	Liverpool, Walton
tabling member printed	Steve Rotheram
uin	211473
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>This information is not held centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:16:42 answering member 3918 label Biography information for Jane Ellison
tabling member	4035 label Biography information for Steve Rotheram

100195

registered interest
date	21/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to simplify the provision and commissioning of secondary care; and if he will make a statement.
tabling member constituency	Mid Derbyshire
tabling member printed	Pauline Latham
uin	211309
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>In considering the commissioning and provision of secondary care, it is for commissioners and clinicians locally to design and deliver the models of care that are going to provide the best outcomes for patients.</p><p> </p><p> </p><p> </p><p>NHS England has published a Five Year Forward View which describes the vision for the future of the NHS, including increasing the involvement of General Practitioners in the provision of services traditionally placed in secondary care through ‘Multispecialty Community Providers’ and ‘Primary and Acute Care Systems’. A copy of the Five Year Forward View is attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:11:44 answering member 3918 label Biography information for Jane Ellison attachment 1 file name NHS England- Five Year Forward View.pdf title NHS England- Five Year Forward View
tabling member	4025 label Biography information for Mrs Pauline Latham

100196

registered interest
date	21/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the signature authorising Individual Funding Requests made to NHS England for Gamma Knife treatment by University College Hospital London, Queen Square, is that of a senior clinician employed by University College Hospital London.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	211310
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We are advised by NHS England that the clinician who authorises Individual Funding Requests for Gamma Knife treatment to be undertaken at the Queens Square Radiology Centre Ltd (QSRC) is a surgeon at the National Hospital for Neurosurgery and Neurology (NHNN), part of University College London Hospitals NHS Foundation Trust (UCLH).</p><p> </p><p> </p><p> </p><p>Gamma Knife treatment is not undertaken by UCLH but by the private company QSRC, which is based at NHNN but has no formal relationship with UCLH.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:54:23 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

99850

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to ensure the routine commissioning of cough assist machines in the West Midlands.
tabling member constituency	Sutton Coldfield
tabling member printed	Mr Andrew Mitchell
uin	211129
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders, such as muscular dystrophy. NHS England has published a neurosciences specification, which sets out what providers must have in place to offer high quality care and treatment for patients.</p><p> </p><p> </p><p> </p><p>The neurosciences service specification describes when patients should be referred to specialist respiratory services and the circumstances in which cough assist devices should be considered. It is available from the NHS England website at this link:</p><p> </p><p> </p><p> </p><p>http://www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf.</p><p> </p><p> </p><p> </p><p>A copy of this document has also been attached.</p><p> </p><p> </p><p> </p><p>The equipment and respiratory support of cough assist is the commissioning responsibility of clinical commissioning groups, delivered through local specialist respiratory services, according to any local clinical commissioning policy they may have in place.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:43:52 answering member 3918 label Biography information for Jane Ellison attachment 1 file name NHS England neuroscience service specification.pdf title Neurosciences service specification
tabling member	1211 label Biography information for Mr Andrew Mitchell

99855

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with (a) the Haemophilia Society, (b) the Manor House Group, (c) Tainted Blood, (d) the Hepatitis C Trust and (e) the Contaminated Blood campaign in the last two years.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211077
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>In the last two years, the Department has met with the Haemophilia Society about haemophilia services, grant funding for the Society and support for haemophiliacs infected or affected by HIV and/or hepatitis C through historic treatment with NHS-supplied blood products.</p><p> </p><p> </p><p> </p><p>The Department has met with the Hepatitis C Trust about hepatitis C services, grant funding for the Trust and support for individuals infected or affected by hepatitis C through historic treatment with NHS-supplied blood or blood products.</p><p> </p><p> </p><p> </p><p>The Department has met with representatives of the Manor House Group, Tainted Blood and the Contaminated Blood Campaign about support for individuals infected or affected by HIV and/or hepatitis C through historic treatment with NHS-supplied blood or blood products, the scientific and clinical evidence for hepatitis C, and haemophilia services.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:05:12 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99857

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) first-stage payments and (b) second-stage payments have been made from the Skipton Fund to the estates of individuals who contracted hepatitis C following NHS treatment with blood products between 1970 and 1995 but who died before 29 August 2003; what the total amount of money paid out to these estates was; how many total applications for lump sum payments were made by the families and dependants of these victims from 10 January to the end of March 2011; how many applications were refused on the basis that they came in too late; whether his Department has received any representations from (i) the families of victims, (ii) campaign groups and (iii) the Skipton Fund or Caxton Foundation about the time available to apply.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211080
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The following table sets out the number of payments and total paid out by Skipton Fund Ltd to the estates of individuals who contracted hepatitis C through treatment with NHS supplied blood or blood products prior to 1991 and who died prior to 29 August 2003.</p><p> </p><p> </p><p> </p><table><tbody><tr><td rowspan="2"><p> </p></td><td colspan="2"><p>(a) Stage 1</p></td><td colspan="2"><p>(b) Of whom have also received Stage 2*</p></td></tr><tr><td><p>Number of payments</p></td><td><p>Total cost (£)</p></td><td><p>Number of payments</p></td><td><p>Total cost (£)</p></td></tr><tr><td><p>For all individuals</p></td><td><p>472</p></td><td><p>9,440,000.00</p></td><td><p>258</p></td><td><p>12,900,000.00</p></td></tr><tr><td><p>Comprising individuals with a bleeding disorder treated with plasma derived products</p></td><td><p>441</p></td><td><p>8,820,000.00</p></td><td><p>236</p></td><td><p>11,800,000.00</p></td></tr><tr><td><p>And individuals treated with a whole blood transfusion</p></td><td><p>31</p></td><td><p>620,000.00</p></td><td><p>22</p></td><td><p>1,100,000.00</p></td></tr></tbody></table><p> </p><p>*Stage 2 payment is made for individuals who received a stage 1 payment and progressed to more severe hepatitis C related disease.</p><p> </p><p> </p><p> </p><p>There were 81 such applications before 31 March 2011. However, the deadline initially set of 31 March 2011 was for registrations with the Skipton Fund and not completed applications. No applications have been refused to date for missing the deadline.</p><p> </p><p> </p><p> </p><p>The Department received representations from campaign groups and families of deceased individuals in relation to the deadline, and worked with the Skipton Fund in 2011 to agree that any late registrations would be processed, provided the individual registering had good reason for the late registration.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:01:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

99858

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether benefits an individual receives are taken into account when deciding an individual's eligibility for discretionary financial payments from the (a) Caxton Foundation, (b) Macfarlane Trust and (c) Eileen Trust.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211078
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>When deciding an individual's eligibility for discretionary financial payments, the Caxton Foundation, Macfarlane Trust and Eileen Trust, all take benefits into account as part of overall household income.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:03:20 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson